Navigation Links
Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Date:3/15/2010

bott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 83,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

(1) MACE is a composite measure of key efficacy and safety endpoints and includes cardiac death,

heart attack (myocardial infarction) and ischemia-driven target lesion revascularization.

SOURCE Abbott

Back to top

RELATED LINKS
http://www.abbott.com

'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)...  According to data released today by the Centers ... Medicare Part D premium is expected to remain stable ... projected, the Pharmaceutical Care Management Association (PCMA) said. ... a bright spot in American health care. By offering ... using cutting edge, cost-saving tools like pharmacy networks and ...
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a ... today reported its financial results for the quarter ended June ... of 2014 to the same period of 2013: , ... , t:slim Pump shipments grew 64 percent to 2,235 ... ended June 30, 2014 to the same period of 2013: ...
(Date:7/31/2014)... July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... on its pipeline and new product development efforts. In ... initiate a Phase 2a study of AZ-002 (Staccato ... the management of patients with acute repetitive seizures. ... -based product candidates for development - AZ-008 and ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6
... Pharmaceuticals, Inc. (NYSE: WPI ), today confirmed ... of Delaware has ruled that Watson,s generic version of ... No. 6,264,981 (the ,981 Patent).  The Company said that ... all available options, including an appeal. ...
... 25, 2011 Approximately five percent of prescriptions submitted ... a 30-day period during 2009 included a "dispense as ... patients demand the dispensing of a specific brand-name drug ... care system up to $7.7 billion annually, according to ...
Cached Medicine Technology:Watson Confirms District Court Ruling in Generic Fentora® Patent Suit 2CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs 2CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs 3
(Date:8/1/2014)... use among young people has spiked, with 29.3 percent ... at least once and 17 percent admitting to regular use ... ‘Yes to Life,’ volunteers from the Church of Scientology of ... information about drugs, to help reverse this alarming trend. , ... Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies of ...
(Date:8/1/2014)... the University of California, San Diego School of Medicine ... chili peppers produces chronic activation of a receptor ... reaction that ultimately reduces the risk of colorectal tumors. ... 2014 issue of The Journal of Clinical Investigation ... was originally discovered in sensory neurons, where it acts ...
(Date:8/1/2014)... regulating appetite and whole-body metabolism. A protein known as ... intake and body weight, but the identity of the ... A new study in the Journal of Clinical ... of neuron known as pro-opiomelanocortin (POMC) neurons is critical ... Diano and colleagues at Yale University School of Medicine ...
(Date:8/1/2014)... Bronson Gray HealthDay Reporter FRIDAY, ... work in manufacturing jobs may have significantly less endurance than those ... of 32 people -- half were obese, half were of normal ... were about 60 percent longer. Obesity also was associated with ... Being older -- 50 to 65 years of age -- ...
(Date:8/1/2014)... The U.S. Food and Drug Administration announced on Friday ... fight type 2 diabetes. Jardiance (empagliflozin) "can ... to control blood sugar levels in the overall management ... of Drug Evaluation II in the FDA,s Center for ... The FDA also recommended that Jardiance be used ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:FDA Approves New Type 2 Diabetes Drug 2
... standards for elder care in nursing homes are the only ... to prevent serious safety violations, according to a new study ... ,The majority of the nation's elderly and disabled in ... national recommendations for safe care, the study found. While no ...
... approved Torisel (temsirolimus) for the treatment of a certain type ... Torisel was approved based on a study that showed use ... carcinoma. The drug is an enzyme inhibitor, a protein that ... ,'We have made significant advances in the battle against kidney ...
... The National Aeronautics and Space Administration (NASA) has ... disasters.,In fact it goes further than others and ... to push Earth past "critical tipping points" with "dangerous ... by NASA and the Columbia University Earth Institute appears ...
... might be the brand ambassadors of India. But they could ... happened in the case of Thirumurthy Nakka Boomaiah , ... of Tamil Nadu. ,He has been sentenced to ... a flight from London to Philadelphia and assaulting flight attendants. ...
... rubber combined with sulphur to improve its overall strength ... is difficult to reform and reuse old tyres. The ... a landfill, a process that releases heavy metals and other ... David Isaac and colleagues at Swansea University, UK, have shown ...
... technology is expected to help physicians better classify breast ... by the FDA that allows doctors to measure ... new technique may significantly reduce the need for biopsies. ... percent of biopsies turn up positive for cancer. ...
Cached Medicine News:Health News:Policy Changes Have Direct Effect on Nursing Home Care 2Health News:Policy Changes Have Direct Effect on Nursing Home Care 3Health News:FDA: New Drug for Advance Kidney Cancer 2Health News:Global Warming Disaster Closer Than Thought, Says NASA 2Health News:Global Warming Disaster Closer Than Thought, Says NASA 3Health News:Indian Engineer Sentenced for Groping Women During Flight 2
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Perfect for use in the E.R. Stabilizes collateral ligament strains in seconds and allows hand and finger function. Made from 1/8" AliPlast™ PXE. Can be scissor trimmed....
... Control of thumb motion can be difficult ... for persons with spinal cord injuries and ... to cerebral palsy or other motor or ... the thumb for control and coordination. Soft ...
... ThumWrap Splints offer support without the restriction ... mild pain or strain due to repetitive ... the rigid or the flexible stay to ... Washable and breathable, the ThumWrap Splint is ...
Medicine Products: